Sweden
2
2019-09-19
2
2020-05-19
These are the the leading inventors for applications assigned to KANCERA AB:
KANCERA AB based in , SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
#2 | 2018-04-26 ✅ Patent 10,512,634 granted on 2019-12-24Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity
565903 ⎘